Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
HP-501 SR by Hinova Pharmaceuticals for Gouty Arthritis (Gout): Likelihood of Approval
HP-501 SR is under clinical development by Hinova Pharmaceuticals and currently in Phase II for Gouty Arthritis (Gout). According to...
HP-501 SR by Hinova Pharmaceuticals for Hyperuricemia: Likelihood of Approval
HP-501 SR is under clinical development by Hinova Pharmaceuticals and currently in Phase II for Hyperuricemia. According to GlobalData, Phase...
HP-518 by Hinova Pharmaceuticals for Metastatic Castration-Resistant Prostate Cancer (mCRPC): Likelihood of Approval
HP-518 is under clinical development by Hinova Pharmaceuticals and currently in Phase I for Metastatic Castration-Resistant Prostate Cancer (mCRPC). According...